Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal

BACKGROUND: The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can be profoundly reduced by cholesterol-lowering therapy, and current guidelines for FH advocate ambitious low-density lipoprotein cholesterol (LDL-C) goals. In the present study, we determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huijgen, Roeland, Kindt, Iris, Verhoeven, Sjoerd B. J., Sijbrands, Eric J. G., Vissers, Maud N., Kastelein, John J. P., Hutten, Barbara A.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821409/
https://www.ncbi.nlm.nih.gov/pubmed/20169164
http://dx.doi.org/10.1371/journal.pone.0009220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821409/
https://www.ncbi.nlm.nih.gov/pubmed/20169164
http://dx.doi.org/10.1371/journal.pone.0009220

Ejemplares similares